Here’s Why the US Corporate Earnings Decline Won’t Hurt the Dow Jones

For the first time since 2016, U.S. corporate earnings are projected to drop by 0.8 percent per share in the first quarter of 2019. But, the projection had no visible impact on the Dow Jones and the rest of the U.S. stock market. In December 2018, Wall Street analysts forecasted U.S. corporate earnings to grow by 3.3 percent. The data provided by FactSet obtained by FT show that analysts have slashed their forecast from 3.3 percent growth to a 0.8 percent decline. The drop in U.S. corporate earnings comes in a period in which large conglomerates, especially in the tech

The post Here’s Why the US Corporate Earnings Decline Won’t Hurt the Dow Jones appeared first on CCN

News – CCN

Pharma Stocks Decline as House Democrats Investigate Drug Prices

Stock prices of twelve of the largest pharmaceutical companies in the USA have fallen sharply after the commencement of a Congressional investigation into prescription drug pricing practices. In a statement released yesterday, it was revealed that the House Oversight Committee chaired by Senator Elijah Cummings (D-Md) sent letters requesting information about their pricing strategies to AbbVie, Amgen,

The post Pharma Stocks Decline as House Democrats Investigate Drug Prices appeared first on CCN

News – CCN